METHIMAZOLE

METHIMAZOLE was reported 7994 times

These side effects are most commonly reported by patients taking METHIMAZOLE:

# Side effect Count
0 DRUG INEFFECTIVE 658
1 OFF LABEL USE 495
2 FATIGUE 453
3 HYPERTHYROIDISM 416
4 NAUSEA 387
5 DIARRHOEA 345
6 HEADACHE 334
7 PAIN 314
8 DIZZINESS 308
9 DYSPNOEA 282
10 AGRANULOCYTOSIS 261
11 ASTHENIA 228
12 ARTHRALGIA 222
13 ANXIETY 218
14 RASH 215
15 PRURITUS 210
16 CONDITION AGGRAVATED 208
17 PRODUCT USE IN UNAPPROVED INDICATION 203
18 WEIGHT DECREASED 199
19 DEATH 187
20 MUSCLE SPASMS 181
21 PYREXIA 180
22 FALL 172
23 MALAISE 171
24 VOMITING 171
25 HYPOTHYROIDISM 160
26 ALOPECIA 154
27 COUGH 154
28 INSOMNIA 153
29 PNEUMONIA 145
30 PRODUCT USE ISSUE 143
31 THYROTOXIC CRISIS 139
32 PAIN IN EXTREMITY 136
33 BACK PAIN 131
34 ATRIAL FIBRILLATION 130
35 DECREASED APPETITE 127
36 MYALGIA 125
37 HYPOTENSION 123
38 ACUTE KIDNEY INJURY 121
39 NEUTROPENIA 121
40 TINNITUS 121
41 PRODUCT DOSE OMISSION ISSUE 120
42 WEIGHT INCREASED 120
43 ABDOMINAL PAIN 118
44 CONSTIPATION 118
45 ANAEMIA 117
46 CARDIAC ARREST 116
47 BLOOD PRESSURE INCREASED 110
48 PALPITATIONS 109
49 CARDIAC FAILURE 108
50 EMOTIONAL DISTRESS 107
51 FOETAL EXPOSURE DURING PREGNANCY 107
52 HYPERTENSION 107
53 DEPRESSION 105
54 ABDOMINAL PAIN UPPER 103
55 GAIT DISTURBANCE 102
56 BLOOD GLUCOSE INCREASED 101
57 FEELING ABNORMAL 101
58 DRUG-INDUCED LIVER INJURY 97
59 DRUG INTERACTION 96
60 URINARY TRACT INFECTION 96
61 CHEST PAIN 94
62 GRAVES^ DISEASE 92
63 PERIPHERAL SWELLING 92
64 ABDOMINAL DISCOMFORT 91
65 ENDOCRINE OPHTHALMOPATHY 91
66 TREMOR 91
67 RENAL FAILURE 90
68 COVID-19 88
69 DRUG HYPERSENSITIVITY 88
70 PARAESTHESIA 87
71 TREATMENT NONCOMPLIANCE 84
72 OEDEMA PERIPHERAL 82
73 NASOPHARYNGITIS 80
74 OROPHARYNGEAL PAIN 80
75 URTICARIA 79
76 WHITE BLOOD CELL COUNT DECREASED 79
77 CHRONIC KIDNEY DISEASE 78
78 RESPIRATORY FAILURE 78
79 DISCOMFORT 76
80 MUSCULAR WEAKNESS 76
81 SOMNOLENCE 76
82 TACHYCARDIA 76
83 HYPERHIDROSIS 75
84 HYPERSENSITIVITY 74
85 CONTUSION 73
86 CEREBROVASCULAR ACCIDENT 72
87 DRY SKIN 72
88 HEART RATE INCREASED 72
89 MATERNAL EXPOSURE DURING PREGNANCY 72
90 PANCYTOPENIA 72
91 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 71
92 INFECTION 71
93 THYROID DISORDER 68
94 ABDOMINAL DISTENSION 66
95 CARDIOGENIC SHOCK 66
96 INFLUENZA 66
97 VISION BLURRED 66
98 FEBRILE NEUTROPENIA 65
99 GASTROINTESTINAL HAEMORRHAGE 65
100 THROMBOCYTOPENIA 65
101 EXPOSURE DURING PREGNANCY 64
102 SEPSIS 64
103 SINUSITIS 64
104 PLEURAL EFFUSION 63
105 VISUAL IMPAIRMENT 63
106 CONFUSIONAL STATE 62
107 ERYTHEMA 62
108 HYPOAESTHESIA 62
109 BASEDOW^S DISEASE 61
110 EPISTAXIS 61
111 TOXICITY TO VARIOUS AGENTS 60
112 CHEST DISCOMFORT 59
113 DEAFNESS NEUROSENSORY 59
114 GASTROOESOPHAGEAL REFLUX DISEASE 59
115 ILLNESS 59
116 INJECTION SITE PAIN 59
117 PREMATURE BABY 59
118 THERAPY NON-RESPONDER 59
119 EYE PAIN 58
120 INCORRECT DOSE ADMINISTERED 57
121 LEUKOPENIA 57
122 BRADYCARDIA 56
123 FLUSHING 56
124 SEPTIC SHOCK 56
125 STRESS 56
126 DEHYDRATION 55
127 DYSPHAGIA 55
128 HYPOKALAEMIA 55
129 BLOOD PRESSURE DECREASED 54
130 CARDIAC FAILURE CONGESTIVE 54
131 DIPLOPIA 54
132 IMPAIRED QUALITY OF LIFE 54
133 CHILLS 53
134 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 53
135 MEMORY IMPAIRMENT 53
136 ARTHRITIS 52
137 BALANCE DISORDER 52
138 GOITRE 52
139 ASTHMA 51
140 DYSPEPSIA 50
141 PLATELET COUNT DECREASED 50
142 HAEMOGLOBIN DECREASED 49
143 INJURY 49
144 MULTIPLE ORGAN DYSFUNCTION SYNDROME 49
145 OCULAR HYPERAEMIA 49
146 DISEASE RECURRENCE 48
147 LOSS OF CONSCIOUSNESS 48
148 MIGRAINE 47
149 MUSCULOSKELETAL STIFFNESS 47
150 RENAL IMPAIRMENT 47
151 BLOOD CREATININE INCREASED 46
152 BURNING SENSATION 44
153 HEPATIC ENZYME INCREASED 44
154 PRODUCT QUALITY ISSUE 44
155 ALANINE AMINOTRANSFERASE INCREASED 43
156 DYSPHONIA 43
157 HYPOACUSIS 43
158 PRODUCT USE COMPLAINT 43
159 RESPIRATORY SYNCYTIAL VIRUS INFECTION 43
160 SWELLING 43
161 THERAPY INTERRUPTED 43
162 BRONCHITIS 42
163 DIABETES MELLITUS 42
164 HYPERKALAEMIA 42
165 INFLUENZA LIKE ILLNESS 42
166 INTENTIONAL PRODUCT USE ISSUE 42
167 NECK PAIN 42
168 SYNCOPE 42
169 DRUG DOSE OMISSION 41
170 STEVENS-JOHNSON SYNDROME 41
171 DEAFNESS PERMANENT 40
172 DRY MOUTH 40
173 SEIZURE 40
174 FLATULENCE 39
175 GASTROINTESTINAL DISORDER 39
176 GENERAL PHYSICAL HEALTH DETERIORATION 39
177 JAUNDICE 39
178 LIVER INJURY 39
179 EYE SWELLING 38
180 HALLUCINATION 38
181 MOBILITY DECREASED 38
182 PRODUCTIVE COUGH 38
183 CARDIAC DISORDER 37
184 DRUG INTOLERANCE 37
185 EAR DISCOMFORT 37
186 FEELING HOT 37
187 FLUID RETENTION 37
188 HOSPITALISATION 37
189 INJECTION SITE ERYTHEMA 37
190 JOINT SWELLING 37
191 NEUROPATHY PERIPHERAL 37
192 ASPARTATE AMINOTRANSFERASE INCREASED 36
193 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36
194 ECONOMIC PROBLEM 36
195 ELECTROCARDIOGRAM QT PROLONGED 36
196 JAUNDICE CHOLESTATIC 36
197 NASAL CONGESTION 36
198 OVERDOSE 36
199 SWELLING FACE 36
200 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36
201 BLOOD ALKALINE PHOSPHATASE INCREASED 35
202 CONCOMITANT DISEASE AGGRAVATED 35
203 DISEASE PROGRESSION 35
204 DRY EYE 35
205 EXOPHTHALMOS 35
206 INTENTIONAL PRODUCT MISUSE 35
207 PRODUCT SUBSTITUTION ISSUE 35
208 PULSELESS ELECTRICAL ACTIVITY 35
209 DYSPNOEA EXERTIONAL 34
210 HERPES ZOSTER 34
211 NERVOUSNESS 34
212 BLOOD THYROID STIMULATING HORMONE DECREASED 33
213 OSTEOARTHRITIS 33
214 PHYSICAL DISABILITY 33
215 PREMATURE DELIVERY 33
216 WHEEZING 33
217 AGITATION 32
218 CHOLESTASIS 32
219 EYE IRRITATION 32
220 HEPATIC FAILURE 32
221 LETHARGY 32
222 LIVER FUNCTION TEST INCREASED 32
223 NO ADVERSE EVENT 32
224 PULMONARY EMBOLISM 32
225 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 32
226 BLISTER 31
227 GLYCOSYLATED HAEMOGLOBIN INCREASED 31
228 HOT FLUSH 31
229 HYPONATRAEMIA 31
230 PSORIASIS 31
231 THROAT IRRITATION 31
232 UPPER RESPIRATORY TRACT INFECTION 31
233 ARRHYTHMIA 30
234 DYSGEUSIA 30
235 HYPOGLYCAEMIA 30
236 OSTEOPOROSIS 30
237 POLLAKIURIA 30
238 POLYARTHRITIS 30
239 TASTE DISORDER 30
240 THYROTOXIC PERIODIC PARALYSIS 30
241 TREATMENT FAILURE 30
242 WHITE BLOOD CELL COUNT INCREASED 30
243 BLOOD BILIRUBIN INCREASED 29
244 CATARACT 29
245 DISABILITY 29
246 DRUG EXPOSURE DURING PREGNANCY 29
247 ENCEPHALOPATHY 29
248 HAEMORRHAGE 29
249 INTERNATIONAL NORMALISED RATIO INCREASED 29
250 NEUTROPHIL COUNT DECREASED 29
251 RHEUMATOID ARTHRITIS 29
252 VERTIGO 29
253 EAR PAIN 28
254 MULTIPLE SCLEROSIS RELAPSE 28
255 MYOCARDIAL INFARCTION 28
256 SLEEP DISORDER 28
257 SWOLLEN TONGUE 28
258 ACUTE HEPATIC FAILURE 27
259 CONJUNCTIVITIS 27
260 DEVICE ISSUE 27
261 HYPERGLYCAEMIA 27
262 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27
263 PANCREATITIS ACUTE 27
264 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 27
265 PULMONARY OEDEMA 27
266 RASH ERYTHEMATOUS 27
267 SHOCK 27
268 SKIN EXFOLIATION 27
269 THERAPY CESSATION 27
270 ADVERSE DRUG REACTION 26
271 HAEMOPTYSIS 26
272 HYPOXIA 26
273 LYMPHADENOPATHY 26
274 RHABDOMYOLYSIS 26
275 VENTRICULAR FIBRILLATION 26
276 ANGIOEDEMA 25
277 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 25
278 ANTITHYROID ARTHRITIS SYNDROME 25
279 DYSURIA 25
280 EYE DISORDER 25
281 HAEMATOCHEZIA 25
282 INFUSION SITE PAIN 25
283 INTENTIONAL OVERDOSE 25
284 LIMB INJURY 25
285 RHINORRHOEA 25
286 THYROID MASS 25
287 VENTRICULAR TACHYCARDIA 25
288 GAIT INABILITY 24
289 HAEMODYNAMIC INSTABILITY 24
290 HEPATOTOXICITY 24
291 LACRIMATION INCREASED 24
292 PERICARDIAL EFFUSION 24
293 PNEUMONIA ASPIRATION 24
294 TYPE 2 DIABETES MELLITUS 24
295 UNEVALUABLE EVENT 24
296 BONE PAIN 23
297 CARDIO-RESPIRATORY ARREST 23
298 CELLULITIS 23
299 DISTURBANCE IN ATTENTION 23
300 DYSKINESIA 23
301 HEPATITIS 23
302 INFLAMMATION 23
303 ACUTE RESPIRATORY FAILURE 22
304 ASCITES 22
305 HEART RATE DECREASED 22
306 HEPATIC STEATOSIS 22
307 HYPERBILIRUBINAEMIA 22
308 HYPERCALCAEMIA 22
309 LIVER DISORDER 22
310 MALIGNANT NEOPLASM PROGRESSION 22
311 MUSCULOSKELETAL PAIN 22
312 NIGHT SWEATS 22
313 OEDEMA 22
314 OXYGEN SATURATION DECREASED 22
315 PANCREATITIS 22
316 PRODUCT DISPENSING ERROR 22
317 PRODUCT DOSE OMISSION 22
318 SINUS BRADYCARDIA 22
319 SUICIDAL IDEATION 22
320 UPPER GASTROINTESTINAL HAEMORRHAGE 22
321 WITHDRAWAL SYNDROME 22
322 ACCIDENTAL EXPOSURE TO PRODUCT 21
323 ANAPHYLACTIC REACTION 21
324 BLOOD CREATINE PHOSPHOKINASE INCREASED 21
325 END STAGE RENAL DISEASE 21
326 HEPATITIS CHOLESTATIC 21
327 LIMB DISCOMFORT 21
328 PULMONARY HYPERTENSION 21
329 PULMONARY MASS 21
330 SINUS TACHYCARDIA 21
331 THERAPEUTIC RESPONSE DECREASED 21
332 UNRESPONSIVE TO STIMULI 21
333 AMNESIA 20
334 COMPLETED SUICIDE 20
335 CROHN^S DISEASE 20
336 DRUG RESISTANCE 20
337 HAEMATOCRIT DECREASED 20
338 IRRITABLE BOWEL SYNDROME 20
339 ORAL DISORDER 20
340 RESPIRATORY DISTRESS 20
341 STOMATITIS 20
342 SUICIDE ATTEMPT 20
343 THYROID FUNCTION TEST ABNORMAL 20
344 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 20
345 THYROIDITIS 20
346 ADVERSE EVENT 19
347 APHASIA 19
348 BLOOD PRESSURE SYSTOLIC INCREASED 19
349 BLOOD THYROID STIMULATING HORMONE INCREASED 19
350 DEAFNESS 19
351 EYE PRURITUS 19
352 HIP FRACTURE 19
353 IRRITABILITY 19
354 MENTAL STATUS CHANGES 19
355 METABOLIC ACIDOSIS 19
356 OSTEOPENIA 19
357 PAIN IN JAW 19
358 PHOTOPHOBIA 19
359 PURPURA 19
360 RENAL FAILURE ACUTE 19
361 RENAL INJURY 19
362 ROAD TRAFFIC ACCIDENT 19
363 SEASONAL ALLERGY 19
364 SKIN DISCOLOURATION 19
365 SURGERY 19
366 THROMBOSIS 19
367 AGEUSIA 18
368 BLOOD CHOLESTEROL INCREASED 18
369 BLOOD POTASSIUM DECREASED 18
370 BLOOD UREA INCREASED 18
371 BLOOD URINE PRESENT 18
372 DEEP VEIN THROMBOSIS 18
373 DYSMORPHISM 18
374 DYSSTASIA 18
375 EXTRA DOSE ADMINISTERED 18
376 GASTRITIS 18
377 HEPATIC FUNCTION ABNORMAL 18
378 INJECTION SITE PRURITUS 18
379 LUNG DISORDER 18
380 MYELOSUPPRESSION 18
381 SPEECH DISORDER 18
382 STAPHYLOCOCCAL INFECTION 18
383 THERAPEUTIC RESPONSE UNEXPECTED 18
384 TONSILLITIS 18
385 URINARY INCONTINENCE 18
386 BLOOD POTASSIUM INCREASED 17
387 BONE MARROW FAILURE 17
388 BRAIN INJURY 17
389 COGNITIVE DISORDER 17
390 CUTANEOUS VASCULITIS 17
391 DELIRIUM 17
392 GENERALISED TONIC-CLONIC SEIZURE 17
393 INFUSION SITE SWELLING 17
394 INJECTION SITE BRUISING 17
395 INTERSTITIAL LUNG DISEASE 17
396 LOW BIRTH WEIGHT BABY 17
397 LUNG NEOPLASM MALIGNANT 17
398 NEOPLASM MALIGNANT 17
399 SKIN DISORDER 17
400 TEMPERATURE INTOLERANCE 17
401 TRANSIENT ISCHAEMIC ATTACK 17
402 ABDOMINAL PAIN LOWER 16
403 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16
404 BLOOD SODIUM DECREASED 16
405 CHOANAL ATRESIA 16
406 CHOLELITHIASIS 16
407 FAECES DISCOLOURED 16
408 GENERALISED OEDEMA 16
409 HALLUCINATION, VISUAL 16
410 LOCAL SWELLING 16
411 ONYCHOCLASIS 16
412 PARKINSON^S DISEASE 16
413 PULMONARY ALVEOLAR HAEMORRHAGE 16
414 RASH PRURITIC 16
415 RESTLESSNESS 16
416 SCIATICA 16
417 SKIN BURNING SENSATION 16
418 THYROXINE FREE INCREASED 16
419 TRANSAMINASES INCREASED 16
420 ABNORMAL BEHAVIOUR 15
421 ANGINA PECTORIS 15
422 BLOOD GLUCOSE DECREASED 15
423 BLOOD PRESSURE FLUCTUATION 15
424 BODY TEMPERATURE DECREASED 15
425 C-REACTIVE PROTEIN INCREASED 15
426 CARDIOMEGALY 15
427 CHOLESTATIC LIVER INJURY 15
428 CIRCULATORY COLLAPSE 15
429 DEMENTIA 15
430 DEPRESSED LEVEL OF CONSCIOUSNESS 15
431 DEPRESSED MOOD 15
432 GINGIVAL BLEEDING 15
433 HAIR TEXTURE ABNORMAL 15
434 HEMIPARESIS 15
435 HYPERLIPIDAEMIA 15
436 HYPERTONIA 15
437 INFUSION RELATED REACTION 15
438 IRON DEFICIENCY ANAEMIA 15
439 LUPUS-LIKE SYNDROME 15
440 MOVEMENT DISORDER 15
441 NEPHROLITHIASIS 15
442 PHARYNGITIS 15
443 PRODUCT DOSE OMISSION IN ERROR 15
444 PSORIATIC ARTHROPATHY 15
445 PULMONARY CONGESTION 15
446 RESPIRATORY TRACT CONGESTION 15
447 SINUS DISORDER 15
448 SLEEP APNOEA SYNDROME 15
449 SYSTEMIC LUPUS ERYTHEMATOSUS 15
450 TUBULOINTERSTITIAL NEPHRITIS 15
451 VENTRICULAR DYSFUNCTION 15
452 VITAMIN D DEFICIENCY 15
453 ABASIA 14
454 ACUTE PULMONARY OEDEMA 14
455 ACUTE RESPIRATORY DISTRESS SYNDROME 14
456 ADRENAL INSUFFICIENCY 14
457 AKATHISIA 14
458 ANHEDONIA 14
459 APLASIA CUTIS CONGENITA 14
460 CAESAREAN SECTION 14
461 CANDIDA INFECTION 14
462 CARDIOMYOPATHY 14
463 CEREBRAL HAEMORRHAGE 14
464 CHROMATURIA 14
465 COLITIS 14
466 COLITIS ULCERATIVE 14
467 CYSTITIS 14
468 DEVICE DISLOCATION 14
469 DEVICE LEAKAGE 14
470 DISSEMINATED INTRAVASCULAR COAGULATION 14
471 DRUG DOSE OMISSION BY DEVICE 14
472 DYSARTHRIA 14
473 FUNGAL INFECTION 14
474 GLOMERULAR FILTRATION RATE DECREASED 14
475 GOUT 14
476 HEART RATE IRREGULAR 14
477 HEPATIC ENCEPHALOPATHY 14
478 HYPOCALCAEMIA 14
479 INFUSION SITE ERYTHEMA 14
480 INTESTINAL OBSTRUCTION 14
481 LIVER FUNCTION TEST ABNORMAL 14
482 LYMPHOPENIA 14
483 MELAENA 14
484 MITRAL VALVE INCOMPETENCE 14
485 NEUTROPHIL COUNT INCREASED 14
486 OCULAR DISCOMFORT 14
487 ORAL CANDIDIASIS 14
488 PNEUMONITIS 14
489 PRODUCT STORAGE ERROR 14
490 PRURITUS GENERALISED 14
491 REBOUND EFFECT 14
492 SPLENOMEGALY 14
493 TOOTH DISORDER 14
494 VAGINAL HAEMORRHAGE 14
495 ALTERED STATE OF CONSCIOUSNESS 13
496 AMENORRHOEA 13
497 ARTHROPATHY 13
498 BLINDNESS 13
499 BONE DISORDER 13
500 BRAIN FOG 13
501 BRAIN OEDEMA 13
502 CRYING 13
503 DEVICE RELATED INFECTION 13
504 DIVERTICULITIS 13
505 DRUG WITHDRAWAL SYNDROME 13
506 FLUID OVERLOAD 13
507 FREQUENT BOWEL MOVEMENTS 13
508 HEAD INJURY 13
509 HERNIA 13
510 HYPERSOMNIA 13
511 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13
512 ISCHAEMIC HEPATITIS 13
513 LIGAMENT SPRAIN 13
514 MATERNAL DRUGS AFFECTING FOETUS 13
515 MEDICATION ERROR 13
516 NEURALGIA 13
517 OSTEOMYELITIS 13
518 PANIC ATTACK 13
519 PULMONARY ARTERIAL HYPERTENSION 13
520 QUALITY OF LIFE DECREASED 13
521 RECTAL HAEMORRHAGE 13
522 RED BLOOD CELL COUNT DECREASED 13
523 RIB FRACTURE 13
524 SKIN ULCER 13
525 UPPER-AIRWAY COUGH SYNDROME 13
526 VASCULITIS 13
527 ATELECTASIS 12
528 AUTOIMMUNE THYROIDITIS 12
529 BEDRIDDEN 12
530 BLOOD IRON DECREASED 12
531 BREAST CANCER 12
532 CARDIAC FAILURE ACUTE 12
533 CARDIOTOXICITY 12
534 COAGULOPATHY 12
535 DEVICE MALFUNCTION 12
536 DISORIENTATION 12
537 DRUG ERUPTION 12
538 EAR INFECTION 12
539 ECZEMA 12
540 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 12
541 EXOMPHALOS 12
542 FOOT DEFORMITY 12
543 FOOT FRACTURE 12
544 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12
545 HAEMATURIA 12
546 HAEMORRHOIDS 12
547 HAIR COLOUR CHANGES 12
548 HAIR DISORDER 12
549 ILL-DEFINED DISORDER 12
550 INJECTION SITE RASH 12
551 INSULIN AUTOIMMUNE SYNDROME 12
552 INSURANCE ISSUE 12
553 IRON DEFICIENCY 12
554 LABORATORY TEST ABNORMAL 12
555 LIP EROSION 12
556 LIP SWELLING 12
557 LIVE BIRTH 12
558 LOCALISED INFECTION 12
559 MADAROSIS 12
560 MUCOSAL INFLAMMATION 12
561 MUSCLE ATROPHY 12
562 NEPHROPATHY 12
563 NIKOLSKY^S SIGN 12
564 NOCTURIA 12
565 PHARYNGOLARYNGEAL PAIN 12
566 PRODUCT PRESCRIBING ISSUE 12
567 PSEUDOMONAS INFECTION 12
568 RESPIRATORY ARREST 12
569 SCAR 12
570 SUPRAVENTRICULAR TACHYCARDIA 12
571 THYROIDECTOMY 12
572 TOXIC NODULAR GOITRE 12
573 UNDERDOSE 12
574 URINARY RETENTION 12
575 ACCIDENTAL OVERDOSE 11
576 ACUTE MYOCARDIAL INFARCTION 11
577 ANKLE FRACTURE 11
578 ATRIAL FLUTTER 11
579 AUTOIMMUNE DISORDER 11
580 BLOOD COUNT ABNORMAL 11
581 DEVICE BREAKAGE 11
582 DEVICE DELIVERY SYSTEM ISSUE 11
583 GALLBLADDER DISORDER 11
584 HYPERTHERMIA 11
585 HYPOKINESIA 11
586 HYPOPHAGIA 11
587 INCREASED APPETITE 11
588 INJECTION SITE HAEMORRHAGE 11
589 INJECTION SITE SWELLING 11
590 INTERVERTEBRAL DISC PROTRUSION 11
591 JOINT INJURY 11
592 KIDNEY TRANSPLANT REJECTION 11
593 MYASTHENIA GRAVIS 11
594 NEEDLE ISSUE 11
595 PARALYSIS 11
596 PERIPHERAL COLDNESS 11
597 PNEUMOTHORAX 11
598 POST PROCEDURAL COMPLICATION 11
599 PRODUCT ADMINISTRATION ERROR 11
600 RASH GENERALISED 11
601 RENAL DISORDER 11
602 RESPIRATORY DISORDER 11
603 SARS-COV-2 TEST POSITIVE 11
604 SEROTONIN SYNDROME 11
605 THYROTOXIC MYOPATHY 11
606 TORSADE DE POINTES 11
607 WOUND 11
608 ABNORMAL LOSS OF WEIGHT 10
609 ACTIVITIES OF DAILY LIVING IMPAIRED 10
610 ANGER 10
611 ANOSMIA 10
612 ANTI-THYROID ANTIBODY INCREASED 10
613 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 10
614 BODY HEIGHT DECREASED 10
615 COMA 10
616 CONSCIOUSNESS FLUCTUATING 10
617 CYANOSIS 10
618 DIABETIC KETOACIDOSIS 10
619 DRUG EFFECT LESS THAN EXPECTED 10
620 ECCHYMOSIS 10
621 EJECTION FRACTION DECREASED 10
622 ESCHERICHIA BACTERAEMIA 10
623 FACIAL PAIN 10
624 FEAR 10
625 FEEDING DISORDER 10
626 FEELING COLD 10
627 FEELING JITTERY 10
628 GASTRIC DISORDER 10
629 GASTRIC ULCER 10
630 HEPATIC CIRRHOSIS 10
631 HEPATOCELLULAR INJURY 10
632 HIATUS HERNIA 10
633 HYPERSENSITIVITY VASCULITIS 10
634 HYPOAESTHESIA ORAL 10
635 HYPOTONIA 10
636 KOUNIS SYNDROME 10
637 LYMPHOCYTE COUNT DECREASED 10
638 MEAN CELL VOLUME DECREASED 10
639 MENTAL DISORDER 10
640 MIXED LIVER INJURY 10
641 MONOCYTE COUNT INCREASED 10
642 MOOD ALTERED 10
643 MOUTH ULCERATION 10
644 PAIN OF SKIN 10
645 PNEUMONIA BACTERIAL 10
646 POST PROCEDURAL HYPOTHYROIDISM 10
647 PRESYNCOPE 10
648 RESPIRATORY TRACT INFECTION 10
649 ROTATOR CUFF SYNDROME 10
650 SKIN FISSURES 10
651 SKIN LESION 10
652 SNEEZING 10
653 SPUTUM DISCOLOURED 10
654 SUBDURAL HAEMATOMA 10
655 SYMPTOM RECURRENCE 10
656 SYSTEMIC CANDIDA 10
657 THERAPEUTIC PRODUCT EFFECT DECREASED 10
658 TOOTHACHE 10
659 TOXIC EPIDERMAL NECROLYSIS 10
660 TOXIC GOITRE 10
661 TRI-IODOTHYRONINE INCREASED 10
662 TYPE 1 DIABETES MELLITUS 10
663 VISUAL ACUITY REDUCED 10
664 ABNORMAL DREAMS 9
665 APLASTIC ANAEMIA 9
666 BACK DISORDER 9
667 BACTERIAL INFECTION 9
668 BASEDOW'S DISEASE 9
669 BILIRUBIN CONJUGATED INCREASED 9
670 BLOOD TEST ABNORMAL 9
671 CARDIAC MURMUR 9
672 CARDIAC TAMPONADE 9
673 CHOLECYSTITIS 9
674 CHRONIC GASTRITIS 9
675 CLOSTRIDIUM DIFFICILE COLITIS 9
676 CLOSTRIDIUM DIFFICILE INFECTION 9
677 CONTRAINDICATED PRODUCT ADMINISTERED 9
678 DECUBITUS ULCER 9
679 EATING DISORDER 9
680 EMOTIONAL DISORDER 9
681 ENTEROCOLITIS 9
682 EOSINOPHILIA 9
683 ERYSIPELAS 9
684 ESSENTIAL HYPERTENSION 9
685 EXPIRED PRODUCT ADMINISTERED 9
686 GLAUCOMA 9
687 HAEMATEMESIS 9
688 HEAD DISCOMFORT 9
689 HYPERTRANSAMINASAEMIA 9
690 IMMUNE SYSTEM DISORDER 9
691 INTENTIONAL DOSE OMISSION 9
692 INTERVERTEBRAL DISC DEGENERATION 9
693 JOINT STIFFNESS 9
694 LACERATION 9
695 LACTIC ACIDOSIS 9
696 LEFT VENTRICULAR HYPERTROPHY 9
697 MAJOR DEPRESSION 9
698 MUSCLE TWITCHING 9
699 MUSCULOSKELETAL CHEST PAIN 9
700 NEONATAL THYROTOXICOSIS 9
701 OCULAR ICTERUS 9
702 ODYNOPHAGIA 9
703 ORAL PAIN 9
704 PLASMA CELL MYELOMA 9
705 POOR QUALITY SLEEP 9
706 PROCTALGIA 9
707 PRODUCT AVAILABILITY ISSUE 9
708 PRODUCT PHYSICAL ISSUE 9
709 PROSTATIC SPECIFIC ANTIGEN INCREASED 9
710 PSYCHOMOTOR HYPERACTIVITY 9
711 RASH MACULAR 9
712 RENAL TUBULAR NECROSIS 9
713 SEDATION 9
714 SKIN LACERATION 9
715 SKIN SENSITISATION 9
716 SPINAL OSTEOARTHRITIS 9
717 THYROID CANCER 9
718 TRICUSPID VALVE INCOMPETENCE 9
719 ULCER 9
720 UPPER LIMB FRACTURE 9
721 VITAMIN D DECREASED 9
722 WEIGHT FLUCTUATION 9
723 ABSCESS 8
724 ACNE 8
725 APHONIA 8
726 AUTOIMMUNE HEPATITIS 8
727 BACTERAEMIA 8
728 BLOOD LACTATE DEHYDROGENASE INCREASED 8
729 BLOOD PRESSURE DIASTOLIC DECREASED 8
730 BLOOD TRIGLYCERIDES INCREASED 8
731 CLONUS 8
732 CONVULSION 8
733 CORONARY ARTERY DISEASE 8
734 CYTOKINE RELEASE SYNDROME 8
735 DELUSION 8
736 DERMATITIS ATOPIC 8
737 DERMATITIS CONTACT 8
738 DIASTOLIC DYSFUNCTION 8
739 ELECTROCARDIOGRAM ABNORMAL 8
740 EXOSTOSIS 8
741 EXPOSURE VIA SKIN CONTACT 8
742 EYE INFECTION 8
743 FOOD POISONING 8
744 FULL BLOOD COUNT DECREASED 8
745 HOSPICE CARE 8
746 HYPERACUSIS 8
747 HYPERVOLAEMIA 8
748 IMPAIRED HEALING 8
749 IMPAIRED WORK ABILITY 8
750 INFUSION SITE PRURITUS 8
751 INTRAOCULAR PRESSURE INCREASED 8
752 ISCHAEMIA 8
753 KIDNEY INFECTION 8
754 LUNG INFILTRATION 8
755 LYMPHOCYTE COUNT INCREASED 8
756 MALNUTRITION 8
757 MASS 8
758 MULTI-ORGAN FAILURE 8
759 MULTIPLE FRACTURES 8
760 MULTIPLE SCLEROSIS 8
761 MUSCLE TIGHTNESS 8
762 NEONATAL RESPIRATORY DISTRESS SYNDROME 8
763 NEPHROGENIC ANAEMIA 8
764 NIGHTMARE 8
765 OVARIAN CYST 8
766 PARAESTHESIA ORAL 8
767 PAROTITIS 8
768 PERIORBITAL SWELLING 8
769 PHARYNGITIS STREPTOCOCCAL 8
770 PHOTOSENSITIVITY REACTION 8
771 PLATELET COUNT INCREASED 8
772 POLYNEUROPATHY 8
773 POLYURIA 8
774 POTENTIATING DRUG INTERACTION 8
775 PRESCRIBED OVERDOSE 8
776 PROCEDURAL PAIN 8
777 PRODUCT ADMINISTRATION INTERRUPTED 8
778 PSYCHOLOGICAL TRAUMA 8
779 PSYCHOTIC DISORDER 8
780 PULMONARY TOXICITY 8
781 RED CELL DISTRIBUTION WIDTH INCREASED 8
782 RESPIRATION ABNORMAL 8
783 RETCHING 8
784 RHINITIS ALLERGIC 8
785 SCAB 8
786 SENSATION OF FOREIGN BODY 8
787 SINUS CONGESTION 8
788 SKIN REACTION 8
789 SKULL MALFORMATION 8
790 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8
791 SPINAL FRACTURE 8
792 STENOTROPHOMONAS MALTOPHILIA PNEUMONIA 8
793 SWELLING OF EYELID 8
794 THERAPEUTIC REACTION TIME DECREASED 8
795 THERAPEUTIC RESPONSE SHORTENED 8
796 THERAPY CHANGE 8
797 THERAPY PARTIAL RESPONDER 8
798 THIRST 8
799 THYROXINE INCREASED 8
800 TRIGEMINAL NEURALGIA 8
801 TYPE V HYPERLIPIDAEMIA 8
802 VENTRICULAR EXTRASYSTOLES 8
803 WRIST FRACTURE 8
804 ABNORMAL FAECES 7
805 ACUTE CORONARY SYNDROME 7
806 AORTIC ANEURYSM 7
807 APATHY 7
808 APHTHOUS ULCER 7
809 ASPIRATION 7
810 AUDITORY DISORDER 7
811 BLOOD CALCIUM INCREASED 7
812 BLOOD CREATININE DECREASED 7
813 BLOOD MAGNESIUM DECREASED 7
814 BLOOD PRESSURE ABNORMAL 7
815 BREAST MASS 7
816 BURSITIS 7
817 CATATONIA 7
818 CENTRAL SEROUS CHORIORETINOPATHY 7
819 CEREBRAL DISORDER 7
820 CEREBRAL INFARCTION 7
821 CHOKING SENSATION 7
822 COELIAC DISEASE 7
823 COLON CANCER 7
824 CONGENITAL ANOMALY 7
825 COORDINATION ABNORMAL 7
826 CRYPTOCOCCOSIS 7
827 DEVICE USE ISSUE 7
828 DIARRHOEA HAEMORRHAGIC 7
829 DRUG ADMINISTRATION ERROR 7
830 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7
831 EAR CONGESTION 7
832 ECTHYMA 7
833 EMPHYSEMA 7
834 EOSINOPHILIC PLEURAL EFFUSION 7
835 ERECTILE DYSFUNCTION 7
836 ERUCTATION 7
837 ESCHERICHIA INFECTION 7
838 EXERCISE TOLERANCE DECREASED 7
839 EYE DISCHARGE 7
840 EYELID MARGIN CRUSTING 7
841 FAECES SOFT 7
842 FEMUR FRACTURE 7
843 FLANK PAIN 7
844 FOETAL GROWTH RESTRICTION 7
845 FOREIGN BODY SENSATION IN EYES 7
846 GASTROINTESTINAL INFLAMMATION 7
847 GASTROINTESTINAL MUCOSAL DISORDER 7
848 GASTROINTESTINAL PAIN 7
849 GRANULOCYTOPENIA 7
850 GUILLAIN-BARRE SYNDROME 7
851 HEPATIC CYTOLYSIS 7
852 HYPOMAGNESAEMIA 7
853 IMPAIRED DRIVING ABILITY 7
854 IMPAIRED GASTRIC EMPTYING 7
855 INFUSION SITE BRUISING 7
856 INJECTION SITE MASS 7
857 INJECTION SITE REACTION 7
858 INJECTION SITE URTICARIA 7
859 INTESTINAL ISCHAEMIA 7
860 JOINT EFFUSION 7
861 LABYRINTHITIS 7
862 LEFT VENTRICULAR DYSFUNCTION 7
863 LEUKOCYTOSIS 7
864 LOWER LIMB FRACTURE 7
865 MACULAR DEGENERATION 7
866 MIDDLE INSOMNIA 7
867 MOOD SWINGS 7
868 MOUTH HAEMORRHAGE 7
869 MUSCLE DISORDER 7
870 MYDRIASIS 7
871 MYOPATHY 7
872 NAIL DISORDER 7
873 OBSTRUCTIVE AIRWAYS DISORDER 7
874 ORAL DISCOMFORT 7
875 ORAL HERPES 7
876 ORTHOSTATIC HYPOTENSION 7
877 PERITONITIS 7
878 PHARYNGEAL ERYTHEMA 7
879 PHARYNGEAL OEDEMA 7
880 PLASMACYTOSIS 7
881 POOR VENOUS ACCESS 7
882 PRODUCT COMMUNICATION ISSUE 7
883 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7
884 RASH PAPULAR 7
885 RED BLOOD CELL COUNT INCREASED 7
886 SCRATCH 7
887 SKIN CANCER 7
888 SKIN HAEMORRHAGE 7
889 SKIN IRRITATION 7
890 STATUS EPILEPTICUS 7
891 STRABISMUS 7
892 THYROXINE FREE DECREASED 7
893 TOOTH EXTRACTION 7
894 TOOTH INFECTION 7
895 TROPONIN INCREASED 7
896 TWIN PREGNANCY 7
897 VIRAL INFECTION 7
898 WERNICKE^S ENCEPHALOPATHY 7
899 YELLOW SKIN 7
900 ABORTION SPONTANEOUS 6
901 ABSCESS LIMB 6
902 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6
903 AGGRESSION 6
904 ANAL FISSURE 6
905 ANOREXIA 6
906 ANTI-THYROID ANTIBODY POSITIVE 6
907 ANURIA 6
908 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6
909 AUTOPHONY 6
910 AXIAL SPONDYLOARTHRITIS 6
911 BACK INJURY 6
912 BIPOLAR DISORDER 6
913 BLEEDING VARICOSE VEIN 6
914 BLEPHARITIS 6
915 BLINDNESS UNILATERAL 6
916 BLOOD ALBUMIN DECREASED 6
917 BLOOD CALCIUM DECREASED 6
918 BUNDLE BRANCH BLOCK LEFT 6
919 CATHETER PLACEMENT 6
920 COLD SWEAT 6
921 COMPRESSION FRACTURE 6
922 COMPUTERISED TOMOGRAM ABNORMAL 6
923 CONGENITAL HYPOTHYROIDISM 6
924 CYTOPENIA 6
925 DEFAECATION URGENCY 6
926 DEFORMITY 6
927 DENTAL CARIES 6
928 DEVICE OCCLUSION 6
929 DISTRIBUTIVE SHOCK 6
930 DRUG PRESCRIBING ERROR 6
931 DYSPNOEA AT REST 6
932 ELECTROLYTE IMBALANCE 6
933 EUSTACHIAN TUBE DYSFUNCTION 6
934 EYE HAEMORRHAGE 6
935 EYELID PTOSIS 6
936 FEAR OF INJECTION 6
937 FEELING DRUNK 6
938 FIBROMYALGIA 6
939 GASTROINTESTINAL NECROSIS 6
940 GINGIVAL PAIN 6
941 GINGIVAL SWELLING 6
942 GINGIVITIS ULCERATIVE 6
943 HAEMATOMA 6
944 HAEMORRHAGE INTRACRANIAL 6
945 HAEMORRHAGIC STROKE 6
946 HAND FRACTURE 6
947 HANGOVER 6
948 HEART DISEASE CONGENITAL 6
949 HEART RATE ABNORMAL 6
950 HEPATIC CYST 6
951 HEPATITIS ACUTE 6
952 HEPATOMEGALY 6
953 HIGH DENSITY LIPOPROTEIN DECREASED 6
954 HORDEOLUM 6
955 HYPERPARATHYROIDISM SECONDARY 6
956 ILEUS PARALYTIC 6
957 IMMUNE THROMBOCYTOPENIA 6
958 INCORRECT DRUG ADMINISTRATION DURATION 6
959 INCORRECT ROUTE OF DRUG ADMINISTRATION 6
960 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6
961 INCREASED TENDENCY TO BRUISE 6
962 INFUSION SITE HAEMORRHAGE 6
963 INFUSION SITE INFECTION 6
964 INFUSION SITE RASH 6
965 INFUSION SITE REACTION 6
966 INJECTION SITE EXTRAVASATION 6
967 JOINT RANGE OF MOTION DECREASED 6
968 LEFT-TO-RIGHT CARDIAC SHUNT 6
969 LOSS OF PROPRIOCEPTION 6
970 LOW DENSITY LIPOPROTEIN INCREASED 6
971 LOWER GASTROINTESTINAL HAEMORRHAGE 6
972 LOWER RESPIRATORY TRACT INFECTION 6
973 LYMPHOMA 6
974 MENORRHAGIA 6
975 MENSTRUATION IRREGULAR 6
976 MUSCULOSKELETAL DISORDER 6
977 MYOCARDIAL ISCHAEMIA 6
978 MYOSITIS 6
979 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 6
980 NASAL SEPTUM DEVIATION 6
981 NEONATAL RESPIRATORY DISTRESS 6
982 NEOPLASM PROGRESSION 6
983 NERVOUS SYSTEM DISORDER 6
984 OBESITY 6
985 OESOPHAGITIS 6
986 OROPHARYNGEAL DISCOMFORT 6
987 ORTHOPNOEA 6
988 OSTEONECROSIS 6
989 PAPILLARY THYROID CANCER 6
990 PERICARDIAL HAEMORRHAGE 6
991 PERICARDITIS 6
992 PERICARDITIS FUNGAL 6
993 PHARYNGEAL SWELLING 6
994 PNEUMONIA KLEBSIELLA 6
995 POLYMYALGIA RHEUMATICA 6
996 PROSTATE CANCER 6
997 PROTEINURIA 6
998 PULSE ABSENT 6
999 RENAL CANCER 6